Ticagrelor, a P2Y12 antagonist, attenuates vascular dysfunction and inhibits atherogenesis in apolipoprotein-E-deficient mice

Authors:

Abstract
No abstract available
Funding Information
  • Boehringer Ingelheim
  • Tanabe-Mitsubishi
  • Kowa
  • Actelion
  • Japan Society for the Promotion of Science KAKENHI (16K09517, 16H05299, 26248050)
  • Takeda Science Foundation
  • Fugaku Trust for Medical Research
  • Vehicle Racing Commemorative Foundation

This publication has 43 references indexed in Scilit: